358 related articles for article (PubMed ID: 29517201)
1. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
3. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
4. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
5. TGF-β/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma.
Tao S; Liu M; Shen D; Zhang W; Wang T; Bai Y
DNA Cell Biol; 2018 Nov; 37(11):909-916. PubMed ID: 30230914
[TBL] [Abstract][Full Text] [Related]
6. Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.
Dituri F; Mazzocca A; Fernando J; Peidrò FJ; Papappicco P; Fabregat I; De Santis F; Paradiso A; Sabbà C; Giannelli G
PLoS One; 2013; 8(6):e67109. PubMed ID: 23826206
[TBL] [Abstract][Full Text] [Related]
7. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Qu K; Lin T; Pang Q; Liu T; Wang Z; Tai M; Meng F; Zhang J; Wan Y; Mao P; Dong X; Liu C; Niu W; Dong S
Oncotarget; 2016 Jun; 7(23):33994-4010. PubMed ID: 27166186
[TBL] [Abstract][Full Text] [Related]
8. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
9. Effect of all-trans retinoic acid on the differentiation of U87 glioma stem/progenitor cells.
Shi Z; Lou M; Zhao Y; Zhang Q; Cui D; Wang K
Cell Mol Neurobiol; 2013 Oct; 33(7):943-51. PubMed ID: 23852377
[TBL] [Abstract][Full Text] [Related]
10. Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.
Wan X; Li ZG; Yingling JM; Yang J; Starbuck MW; Ravoori MK; Kundra V; Vazquez E; Navone NM
Bone; 2012 Mar; 50(3):695-703. PubMed ID: 22173053
[TBL] [Abstract][Full Text] [Related]
11. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Hjelmeland MD; Hjelmeland AB; Sathornsumetee S; Reese ED; Herbstreith MH; Laping NJ; Friedman HS; Bigner DD; Wang XF; Rich JN
Mol Cancer Ther; 2004 Jun; 3(6):737-45. PubMed ID: 15210860
[TBL] [Abstract][Full Text] [Related]
12. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
13. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
Bhola NE; Balko JM; Dugger TC; Kuba MG; Sánchez V; Sanders M; Stanford J; Cook RS; Arteaga CL
J Clin Invest; 2013 Mar; 123(3):1348-58. PubMed ID: 23391723
[TBL] [Abstract][Full Text] [Related]
14. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis.
Kaminska B; Cyranowski S
Adv Exp Med Biol; 2020; 1202():179-201. PubMed ID: 32034714
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic role of Smad4 signaling in colorectal cancer.
Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
Mazzocca A; Fransvea E; Lavezzari G; Antonaci S; Giannelli G
Hepatology; 2009 Oct; 50(4):1140-51. PubMed ID: 19711426
[TBL] [Abstract][Full Text] [Related]
19. Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition.
Zuo ZQ; Chen KG; Yu XY; Zhao G; Shen S; Cao ZT; Luo YL; Wang YC; Wang J
Biomaterials; 2016 Mar; 82():48-59. PubMed ID: 26751819
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]